Contact Us: Sales@finabio.com

Bioconjugation Services

Bioconjugation creates essential reagents for vaccines, immunogens and diagnostics.

Our bioconjugation specialties include:

  • Conjugate vaccines
  • Antibody / protein biotinylation and fluorescent labeling
  • Antibody-enzyme conjugates and other protein-protein linkages
  • Conjugations for peptide immunogens and vaccines
  • Pegylation

We have decades of experience in conjugate vaccines and proprietary chemistry for preparing carbohydrate conjugate vaccines.

Protein Conjugate Vaccine Patent Consulting. Protein conjugate vaccine patents constitute a vast body of prior art. We can help conjugate vaccine makers determine what is an innovation and what is not.

News

  • About FinaBio
    Whitepaper
    Characterization of Fina Biosolutions’ Amino-Dextran
  • About FinaBio

Address

9430 Key West Ave., Suite 200
Rockville, MD 20850
877-346-2246 (877-FinaBio)
301-633-0464 (Andrew Lees, Scientific Director)
Finabio.net
ALees@FinaBio.com

About Us

Fina Biosolutions, LLC was founded in 2006 by Dr. Andrew Lees with an initial focus on helping emerging market vaccine manufacturers learn to make affordable conjugate vaccines. FinaBio has since grown to offer a variety of bioconjugation and protein services. The company is located in the heart of Maryland’s biotechnology corridor.